Best Stock Screeners in 2026 — An Honest Comparison

We chose six screeners that represent distinct approaches to stock screening. We intentionally excluded broker-provided screeners (Schwab, Fidelity, Interactive Brokers) because they require an account and their screeners are add-ons, not core products. We also excluded Bloomberg Terminal and FactSet — they are institutional tools priced at $20,000+/year, not comparable to what individual investors use.

Our selection covers the full spectrum: free and paid, data-only and model-driven, minimalist and visual, established and new.

What it does: AlphaStocks scores 1,595 stocks on a 0-10 scale using five investment models: Graham Fair Value, Buffett Quality Assessment, Piotroski F-Score, Lynch PEG Analysis, and Greenblatt Magic Formula. These five models feed into a composite score that blends four scoring axes into a single rating, updated daily.

What makes it unique: AlphaStocks is the only screener we know of that combines five distinct investment models into a single composite score. The Timing axis — defined as min(Value, Momentum)— is specifically designed to kill value traps. Seven sector-specific scoring profiles adjust weights for banks, REITs, utilities, insurers, and other sector categories. The scoring formula has been validated through walk-forward backtesting on out-of-sample data, delivering +8.4% annual alpha over the S&P 500.

Coverage: S&P 500, S&P MidCap 400, S&P SmallCap 600, and select ADRs — 1,595 stocks total.

Pricing: Free tier shows all 1,595 scores, composite rankings, and the full screener. Premium at $5/month adds fair value estimates, score history charts, and watchlists.

Best for: Value-oriented investors who want systematic, multi-model analysis rather than manual screening. Investors who are skeptical of single-methodology scores and want to see how multiple investment frameworks agree or disagree on a stock.

Limitations: US stocks only — no international coverage beyond select ADRs. No technical chart patterns or real-time price alerts. Newer platform with a smaller user community compared to established tools. Backtest results are hypothetical and do not include transaction costs.

What it does: Finviz (Financial Visualizations) is a fast, filter-heavy screener with 60+ criteria spanning descriptive, fundamental, and technical categories. Its heat maps of the entire market are iconic, and the screener loads results instantly even with complex multi-filter queries.

What makes it unique: Speed and filter depth. Finviz lets you combine dozens of filters simultaneously — market cap, P/E range, RSI, insider ownership, analyst recommendations, chart patterns, and more. The free version is genuinely usable. The visual heat maps make it easy to spot sector-wide moves at a glance.

Pricing: Free with 20-minute delayed data. Finviz Elite at $39.50/month adds real-time data, pre-market/after-hours data, advanced charting, backtesting, and email alerts.

Best for: Technical traders and investors who know exactly what fundamental and technical criteria they want to filter by. Power users who prefer raw control over pre-built scoring.

Limitations: Finviz shows you data but does not score or rate stocks. You see the raw numbers and must interpret them yourself. There is no composite score, no "buy" or "hold" verdict, and no multi-model analysis. The interface is functional but dated. The free tier uses delayed data, which matters for active traders.

What it does: Morningstar is the most recognized name in investment research, famous for its star rating system. It combines quantitative models with human analyst coverage to produce ratings for stocks, ETFs, and mutual funds. The economic moat rating (Wide, Narrow, None) is one of the most cited quality frameworks in investing.

What makes it unique: Morningstar has a deep bench of human equity analysts who write detailed reports and assign fair value estimates. The star rating reflects the gap between analyst fair value and market price. The moat methodology for evaluating competitive advantages is well-respected and thoroughly documented.

Pricing: Basic access is free with limited data. Morningstar Investor (formerly Premium) costs $34.95/month or $249/year. This unlocks analyst reports, fair value estimates, portfolio tools, and the full screener.

Best for: Long-term investors who value detailed analyst narratives and the moat framework. Investors who prefer human-written research over pure quantitative scores. Especially strong for mutual fund and ETF analysis.

Limitations: Expensive at $35/month. The scoring methodology is a single framework — you get the Morningstar view, not a multi-model consensus. Analyst coverage does not extend to all small-cap and mid-cap stocks. The quantitative star rating can lag because it is based on fair value estimates that are updated periodically, not daily. The methodology is somewhat opaque — proprietary models are not fully disclosed.

What it does: Simply Wall St presents stock analysis through beautiful infographic-style visuals. Its signature "snowflake" chart rates each stock on five dimensions — Value, Future, Past, Health, and Dividend — making it immediately clear where a company is strong and where it is weak.

What makes it unique: The visual design is genuinely best-in-class. Simply Wall St makes complex financial data accessible to beginners without dumbing it down. DCF fair value models are shown as interactive charts. The global coverage spans 100,000+ stocks across dozens of markets worldwide.

Pricing: Free tier allows limited company views per month. Premium starts from $10/month (varies by plan), unlocking unlimited analysis, portfolio tracking, and alerts.

Best for: Visual learners and beginner investors who want to understand a stock's strengths quickly. Investors who want global stock coverage. Anyone who finds traditional financial data tables overwhelming.

Limitations: Uses a single proprietary methodology. There is no walk-forward validation or published backtest demonstrating that highly-rated snowflake stocks outperform. The free tier is quite restricted. The DCF models use standard assumptions that may not suit all industries. No multi-model consensus — you get the Simply Wall St view alone.

What it does: Stock Analysis (stockanalysis.com) provides comprehensive financial data, analyst estimates, earnings calendars, IPO tracking, and a stock screener — all largely for free. It covers US stocks, ETFs, and has grown rapidly into one of the most-used free financial data sites.

What makes it unique: The depth of free data is exceptional. You get 10+ years of financial statements, analyst consensus estimates, insider trading data, and institutional holdings without paying anything. The screener supports dozens of fundamental filters. The site is fast and well-organized.

Best for: Data-driven investors who want raw financial data to conduct their own analysis. Anyone who needs comprehensive free access to financial statements, analyst estimates, and earnings data.

Limitations: Stock Analysis is a data aggregator, not an analyst. It does not provide proprietary scoring, ratings, or buy/sell recommendations. You get the data but must build your own framework for interpreting it. There is no composite score, no multi-model consensus, and no backtested validation of any screening strategy.

What it does: Yahoo Finance is the most widely used free financial platform in the world. It offers real-time quotes, news, portfolio tracking, basic screening, earnings calendars, and community conversations. Its stock screener covers fundamental, technical, and analyst-rating filters.

Best for: Quick stock lookups, market news, and basic screening. Yahoo Finance is often the first place investors go when they hear about a stock — and for that use case, it works well.

Limitations: The experience is cluttered with advertisements, especially on the free tier. The screener is basic compared to dedicated screening tools. There is no proprietary scoring, no analytical framework, and no multi-model evaluation. Yahoo Finance Plus ($25/month) adds some analytics but does not fundamentally change the screening experience. Data accuracy has occasionally been flagged by users as inconsistent across different parts of the platform.

There is no single "best" stock screener — the right tool depends on your investing style, experience level, and what you are trying to accomplish. Here is a quick guide:

Many serious investors use more than one tool. You might use Stock Analysis for raw financial data, AlphaStocks for multi-model scoring, and Finviz for quick technical filtering. The tools are complementary, not mutually exclusive.

We evaluated each screener by signing up (both free and paid tiers where available), screening the same set of stocks, and assessing data freshness, scoring transparency, mobile usability, and value for money. All pricing and features were verified as of April 2026 and may change.

Disclosure: AlphaStocks is our product. We have an inherent bias, and we acknowledge it. We tried to be fair: we honestly listed our limitations (US-only coverage, no technical analysis, newer platform) and highlighted where competitors genuinely outperform us (global coverage, visual design, analyst research, filter depth). Read the full AlphaStocks methodology to verify our claims.